Komori
Occurring Fact2721J-Holdings Corp.Information and Communications, Services and Others

Financial Results Summary for the Second Quarter (Interim Period) of the Fiscal Year Ending December 2026 [Japanese GAAP] (Consolidated)

For the interim period of the fiscal year ending December 2026, revenue increased year on year, while the operating loss, ordinary loss and interim net loss all narrowed. However, the Company remained in the red, and operating cash flow remained negative. In its reportable segments, the Web Business was discontinued, and the former Real Estate Business was renamed the Financial Business.

Worth reading
50Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Mixed performance
Direction inferred from the company’s description.
Scale
-134.786
¥ million (interim net loss attributable to owners of the parent)
Wording
Avoiding a definitive answer
How definitive the wording is.

Second Quarter (Interim Period) Consolidated Results for the Fiscal Year Ending December 2026

Subject Entity

株式会社ジェイホールディングス and its consolidated subsidiaries

Target Locations / Products

Higashiyamada Store, Tsukashin Store, stable-type final disposal site in Kurashiki, Okayama Prefecture, cell culture processing facility, and Shokawa Battery Storage Facility

Occurrence30 June 2026 (end of the interim consolidated accounting period)
This disclosure08/14/2026
Cause

The Company recorded an operating loss, ordinary loss, interim net loss attributable to owners of the parent and negative operating cash flow, and uncertainty exists regarding the outlook for future revenue and profit. The Company cites the rebound from the suspension of industrial waste intake for facility maintenance in the same period of the previous year and multiple new orders in the Environmental Solutions Business, and the full-period operation of the cell culture processing facility in the Regenerative Medicine-Related Business, as factors affecting financial performance.

Amount of Impact on Business Performance

Revenue: ¥163.461 million; operating loss: ¥133.239 million; ordinary loss: ¥135.215 million; interim net loss attributable to owners of the parent: ¥134.786 million; cash flow from operating activities: negative ¥105.839 million

Accounting period in which recognized

Second quarter (interim period) of the fiscal year ending December 2026 (1 January 2026 to 30 June 2026)

Impact on Earnings Forecast

There is no change from the earnings forecast announced on 13 February 2026.

Company response

Suspended operations

In the same period of the previous year, there was a period during which intake of industrial waste was suspended due to maintenance of the industrial waste treatment facility.

Measures to prevent recurrence

① Strengthening the revenue base, ② reducing costs, and ③ strengthening and stabilizing the financial base

Outlook

The Company will proceed with repairs to sports facilities and efforts to attract visitors through events, fundraising advisory services in the Financial Business, the acquisition and ownership of solar power generation facilities, expansion of the grid-scale battery storage business, operation of the final disposal site in Kurashiki, Okayama Prefecture, and research and development and exosome sales in the Regenerative Medicine-Related Business. The Shokawa Battery Storage Facility is scheduled for delivery in November 2026, with grid connection scheduled to begin in December 2026, and the Company plans to enter the balancing market in the first half of the next fiscal year.

Event that occurred
ItemDetails
Event nameSecond Quarter (Interim Period) Consolidated Results for the Fiscal Year Ending December 2026
Date of occurrence30 June 2026 (end of the interim consolidated accounting period)
Subject Entity株式会社ジェイホールディングス and its consolidated subsidiaries
Target Locations / ProductsHigashiyamada Store, Tsukashin Store, stable-type final disposal site in Kurashiki, Okayama Prefecture, cell culture processing facility, and Shokawa Battery Storage Facility
CauseThe Company recorded an operating loss, ordinary loss, interim net loss attributable to owners of the parent and negative operating cash flow, and uncertainty exists regarding the outlook for future revenue and profit. The Company cites the rebound from the suspension of industrial waste intake for facility maintenance in the same period of the previous year and multiple new orders in the Environmental Solutions Business, and the full-period operation of the cell culture processing facility in the Regenerative Medicine-Related Business, as factors affecting financial performance.
Amount of Impact on Business PerformanceRevenue: ¥163.461 million; operating loss: ¥133.239 million; ordinary loss: ¥135.215 million; interim net loss attributable to owners of the parent: ¥134.786 million; cash flow from operating activities: negative ¥105.839 million
Accounting period in which recognizedSecond quarter (interim period) of the fiscal year ending December 2026 (1 January 2026 to 30 June 2026)
Impact on Earnings ForecastThere is no change from the earnings forecast announced on 13 February 2026.
Suspended operationsIn the same period of the previous year, there was a period during which intake of industrial waste was suspended due to maintenance of the industrial waste treatment facility.
Measures to prevent recurrence① Strengthening the revenue base, ② reducing costs, and ③ strengthening and stabilizing the financial base
OutlookThe Company will proceed with repairs to sports facilities and efforts to attract visitors through events, fundraising advisory services in the Financial Business, the acquisition and ownership of solar power generation facilities, expansion of the grid-scale battery storage business, operation of the final disposal site in Kurashiki, Okayama Prefecture, and research and development and exosome sales in the Regenerative Medicine-Related Business. The Shokawa Battery Storage Facility is scheduled for delivery in November 2026, with grid connection scheduled to begin in December 2026, and the Company plans to enter the balancing market in the first half of the next fiscal year.
Items this document does not state (14)
Date recognized / date notice receivedType of litigation or proceedingCourt or authorityPlaintiffDefendantDate of filing / date of actionClaim amount / surcharge amountAmount of receivables at risk of non-collection or delayed collectionScheduled resumption dateInvestigation structureDirectors' and officers' liabilityVoting rights ownership percentage before the changeVoting rights ownership percentage after the changePlanned follow-up disclosure

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

The Environmental Solutions Business reported higher revenue and profit, reflecting the rebound from the suspension of industrial waste intake for facility maintenance in the same period of the previous year and multiple new orders. In the Regenerative Medicine-Related Business, revenue was generated after the cell culture processing facility operated for the full period. Meanwhile, the operating loss, ordinary loss, interim net loss and negative operating cash flow continued. As uncertainty remains regarding the outlook for future revenue and profit, the Company states that circumstances continue to exist that raise significant doubt about the going-concern assumption.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Financial Results Summary for the Second Quarter (Interim Period) of the Fiscal Year Ending December 2026 [Japanese GAAP] (Consolidated) | J-Holdings Corp. (2721) timely disclosure | Komori